TCIM
MDGL icon

TIAA CREF Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

TIAA CREF Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.52M Sell
12,173
-682
-5% -$84.8K ﹤0.01% 2130
2018
Q4 		$1.45M Sell
12,855
-348
-3% -$53.9K ﹤0.01% 2134
2018
Q3 		$2.83M Buy
13,203
+434
+3% +$109K ﹤0.01% 1945
2018
Q2 		$3.57M Buy
12,769
+4,727
+59% +$830K ﹤0.01% 1840
2018
Q1 		$939K Sell
8,042
-16,147
-67% -$1.99M ﹤0.01% 2473
2017
Q4 		$2.22M Buy
24,189
+15,885
+191% +$907K ﹤0.01% 2079
2017
Q3 		$374K Buy
8,304
+950
+13% +$17.8K ﹤0.01% 2944
2017
Q2 		$120K Buy
+7,354
New +$115K ﹤0.01% 3103
2015
Q4 		– Sell
-8,824
Closed -$537K – 3145
2015
Q3 		$537K Buy
8,824
+1,394
+19% +$101K ﹤0.01% 2865
2015
Q2 		$580K Buy
7,430
+915
+14% +$76.8K ﹤0.01% 2920
2015
Q1 		$442K Hold
6,515
– – ﹤0.01% 2956
2014
Q4 		$604K Buy
6,515
+158
+2% +$16.3K ﹤0.01% 2904
2014
Q3 		$670K Sell
6,357
-16
-0.3% -$2.23K ﹤0.01% 2846
2014
Q2 		$912K Buy
6,373
+395
+7% +$57.7K ﹤0.01% 2768
2014
Q1 		$902K Sell
5,978
-187
-3% -$36.8K ﹤0.01% 2697
2013
Q4 		$1.13M Buy
6,165
+1,817
+42% +$333K ﹤0.01% 2594
2013
Q3 		$960K Sell
4,348
-142
-3% -$30.2K ﹤0.01% 2631
2013
Q2 		$784K Buy
+4,490
New +$1.17M ﹤0.01% 2734

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

TIAA CREF Investment Management's MDGL Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 5.3% in Q1 2019, selling an estimated $84.8K and leaving 12,173 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

TIAA CREF Investment Management first reported a position in MDGL in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.57M in Q2 2018. 135 funds tracked by Wall St. Rank hold MDGL as of Q1 2019.

  • TIAA CREF Investment Management held 12,173 shares of Madrigal Pharmaceuticals worth $1.52M as of Q1 2019.
  • TIAA CREF Investment Management sold 682 Madrigal Pharmaceuticals shares in Q1 2019, an estimated $84.8K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2130 holding.
  • TIAA CREF Investment Management first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • TIAA CREF Investment Management's Madrigal Pharmaceuticals position peaked at $3.57M in Q2 2018.
  • 135 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.